Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

NCT06263881 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

370

Enrollment

INDUSTRY

Sponsor class

Conditions

Community-acquired Pneumonia
Pneumonia

Interventions

DRUG: Raphamin
DRUG: Placebo

Sponsor

Materia Medica Holding